Awarded Best Start-Up by Israel’s Office of the Chief Scientist of the Ministry of Economy in 2011
For the past 50 years there has been no major breakthrough in stoma care for ostomy patients. Stoma, an artificial opening in the abdomen, is the result of a surgical procedure in which the colon or ileum is cut and brought through the abdominal wall. Medical conditions that may require a stoma include cancer, ulcerative colitis, and Crohn’s disease. The bowel contents automatically pass through this opening and are collected in a bag that is worn 24/7 over the stoma. A typical ostomy appliance includes a shield to protect the skin from the potentially acidic bowel contents and a disposable bag in which waste matter is collected.
People with stomas face numerous obstacles: psychological and social issues, difficulties with bag management, irritated skin around the stoma resulting from adhesive bags and possible bowel leakage, folliculitis, and embarrassing sounds and odors.
Stimatix™ GI’s product line directly addresses these problems and offers reliable, low-profile bowel management appliances that significantly improves the quality of life for people with stomas.
Stimatix GI has developed the Artificial Ostomy Sphincter (AOS) product line with its AOS-1000™ and AOS-C2000™ products, unique colostomy devices that provide voluntary bowel evacuation.
Aesthetically designed and easy to use, the AOS products seal the stoma and eliminate the problems inherent in wearing traditional adhesive bags. These proprietary low- profile colostomy appliances allow people with stoma to decide, at their convenience, when and where to evacuate. With the AOS products, evacuation routine is easier, quicker, and cleaner than ever. And, as the stoma is hermetically sealed, skin irritation and folliculitis are eliminated.
Worldwide there are an estimated 1.5 million people with stoma who use ostomy bags daily.
The ostomy care market is selling $2 billion annually. It is led by three ostomy bag suppliers: ConvaTec, Coloplast, and Hollister, who together hold more than 90% of the market. Ostomy bags comprise over 90% of the market with a CAGR greater than 4%.
Minimally invasive, incision-free, mesh-free repair for pelvic organ prolapse
Improved enteral feeding device
Improved treatment of bladder cancer
All-suture, "all-inside" meniscus repair system
Dual-balloon catheter for treating peripheral vascular disease
Accessible, affordable gait analysis system
Novel dry powder inhaler